MEDIA | Stockhead

Biuotech journalist Tim Boreham has mentioned Avecho in his Stockhead article ‘Biocurious: Sometimes an effective therapy lies not just with the drug, but how it is delivered‘, which explores ASX-listed companies who have developed novel delivery platforms for therapeutics.

“Now called Avecho (ASX:AVE), the company has little resemblance to its predecessor, but TPM lives on. The substance is being used in Avecho’s phase III trial using cannabis to treat insomnia.”

Read the article.